CD274 and head and neck squamous cell carcinoma: Two phase III studies are presently investigating the association of an anti-PD-(L)1 with an anti-CTLA-4 in first line, results are awaited, however other studies, conducted in different set-ups, have sent negative signals which might indicate that this combination may not work in HNSCC.